Please wait while the formulary information is being retrieved.
OVIDREL (HCG ALPHA,RECOMBINANT)
- Follicle stimulation for assisted fertilization
- Ovarian follicle maturation induction
250 mcg/0.5 mL subcutaneous syringe
- Inject 0.5 milliliter (250 mcg) by subcutaneous route once daily for 1 day
Ovarian follicle maturation induction
- Inject 0.5 milliliter (250 mcg) by subcutaneous route once daily for 1 day
- None
Contraindicated
- None
Severe
Moderate
- None
- Abnormal uterine bleeding
- Carcinoma of breast
- Malignant neoplasm of the ovary
- Malignant neoplasm of the uterus
- Ovarian cyst
- Pituitary neoplasm
- Pregnancy
- Primary ovarian failure
Contraindicated
- Ovarian hyperstimulation
- Thromboembolic disorder
Severe
Moderate
- None
OVIDREL (HCG ALPHA,RECOMBINANT)
- Follicle stimulation for assisted fertilization
- Ovarian follicle maturation induction
- None
- Injection site sequelae
More Frequent
Severe
Less Severe
- Ovarian cyst
- Ovarian hyperstimulation syndrome
- Abdominal pain with cramps
- Nausea
- Vomiting
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Thromboembolic disorder
Less Severe
- Skin rash
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Chorionic Gonadotropin,Human (SC)
Safety and effectiveness not established in pediatrics.
- 1 Day – 18 Years
- Safety and effectiveness not established in pediatrics.
Hcg Alpha, Recombinant
- Severity Level:
X
- Additional Notes:
Contraindicated
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Precaution Exists
Hcg Alpha, Recombinant
Insufficient data available
General | Excretion Potential | Effect on Infant | Notes |
Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Follicle stimulation for assisted fertilization | |
Z31.83 | Encounter for assisted reproductive fertility procedure cycle |
Z31.89 | Encounter for other procreative management |
Ovarian follicle maturation induction | |
Z31.83 | Encounter for assisted reproductive fertility procedure cycle |
Z31.89 | Encounter for other procreative management |
0-9 | A-Z |
---|---|
Z31.83 | Encounter for assisted reproductive fertility procedure cycle |
Z31.83 | Encounter for assisted reproductive fertility procedure cycle |
Z31.89 | Encounter for other procreative management |
Z31.89 | Encounter for other procreative management |
Formulary Reference Tool